Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,562 | -8,876 | -6,695 | -3,012 | -1,804 |
| Depreciation Amortization | 55 | 220 | 165 | 110 | 55 |
| Accounts payable and accrued liabilities | 574 | 25 | 264 | 349 | 221 |
| Other Working Capital | 483 | 193 | 87 | -164 | 99 |
| Other Operating Activity | 4,126 | 2,640 | 1,754 | -1 | 84 |
| Operating Cash Flow | $-1,324 | $-5,798 | $-4,426 | $-2,718 | $-1,345 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,274 | -65 | N/A | N/A | N/A |
| Other Investing Activity | -1,000 | -1,000 | -1,000 | 0 | 0 |
| Investing Cash Flow | $-3,274 | $-1,065 | $-1,000 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 6,000 | 6,609 | N/A | N/A |
| Common Stock Issued | 9,691 | N/A | 0 | N/A | N/A |
| Other Financing Activity | 186 | 511 | 0 | 2,323 | 0 |
| Financing Cash Flow | $9,876 | $6,511 | $6,609 | $2,323 | $N/A |
| Beginning Cash Position | 13,923 | 14,275 | 14,275 | 14,275 | 14,275 |
| End Cash Position | 19,201 | 13,923 | 15,458 | 13,880 | 12,930 |
| Net Cash Flow | $5,278 | $-352 | $1,183 | $-395 | $-1,345 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,324 | -5,798 | -4,426 | -2,718 | -1,345 |
| Capital Expenditure | -2,274 | -65 | 0 | N/A | N/A |
| Free Cash Flow | -3,598 | -5,863 | -4,426 | -2,718 | -1,345 |